Glucostratus

Helsinki, Finland Founded: 2017 • Age: 9 yrs
Remote monitoring solution for diabetes patients

About Glucostratus

Glucostratus is a Healthcare company based in Helsinki (Finland) founded in 2017 by German Ezequiel Enriquez, Nicolas Mabragana, and Juhana Karlsson. Remote monitoring solution for diabetes patients. Glucostratus has completed 1 acquisition, including Mendor. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.

Company details

Glucostratus was founded in 2017 in Helsinki, Finland, within the health technology sector. Remote monitoring services for diabetes patients are provided via integration with blood glucose meters, where readings are automatically recorded and transmitted to healthcare professionals. Guidance features for patient management and decision support for treatments are included in the platforms operations.

  • Headquarters Helsinki, Finland
  • Founders German Ezequiel Enriquez, Nicolas Mabragana, Juhana Karlsson
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website glucostratus.com
  • Social LinkedIn
Key Metrics
  • Latest Funding Round
    $56.89K (USD), Grant

    Nov 2018

  • Investors
  • Investments & Acquisitions

Funding Insights of Glucostratus

  • Total Rounds 1
  • Last Round Grant β€” $56,892
  • First Round $56,892

    (Nov 2018)

  • Investors Count 1

All 1 funding rounds of Glucostratus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018$56,892Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Glucostratus

Glucostratus has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Premium access

Investor details for Glucostratus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Glucostratus

3 people are tracked at Glucostratus (3 in leadership).

NameRoleGroup
German Ezequiel Enriquez
Co-FounderLeadership
Nicolas Mabragana
Co-FounderLeadership
Juhana Karlsson
Co-FounderLeadership
Premium access

Complete people profiles for Glucostratus

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Glucostratus

Glucostratus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mendor.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Blood glucose monitoring systems are designed, developed, and commercialized.
mendor.comHelsinki, Finland2006Jun 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Glucostratus

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Glucostratus

3 dated milestones of Glucostratus across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Glucostratus is founded.
  2. Acquisition Acquires Mendor.
  3. Funding First funding round of $57K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Glucostratus

Glucostratus was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Glucostratus is headquartered in Helsinki, Finland.

Glucostratus was founded in 2017 in Helsinki, Finland, within the health technology sector. Remote monitoring services for diabetes patients are provided via integration with blood glucose meters, where readings are automatically recorded and transmitted to healthcare professionals. Guidance features for patient management and decision support for treatments are included in the platforms operations.

Glucostratus has made 1 acquisition, including Mendor.

Glucostratus has 1 investor. Key investors include EIC Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available